These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 15856427

  • 1. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 2. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 15; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 3. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 4. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, de Bock R, Paesmans M, Viscoli C, Calandra T.
    J Clin Oncol; 2013 Mar 20; 31(9):1149-56. PubMed ID: 23358983
    [Abstract] [Full Text] [Related]

  • 5. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gómez C, Ruiz A, García-Carbonero R, Cortés-Funes H.
    Cancer; 1999 Jan 01; 85(1):213-9. PubMed ID: 9921995
    [Abstract] [Full Text] [Related]

  • 6. The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies.
    Cherif H, Johansson E, Björkholm M, Kalin M.
    Haematologica; 2006 Feb 01; 91(2):215-22. PubMed ID: 16461306
    [Abstract] [Full Text] [Related]

  • 7. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 8. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.
    Ann Hematol; 2007 Apr 01; 86(4):263-70. PubMed ID: 17225113
    [Abstract] [Full Text] [Related]

  • 9. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C, Dussart S, Fuhrmann C, Ghesquieres H, Rodrigues I, Geoffrois L, Devaux Y, Lancry L, Chvetzoff G, Bachelot T, Chelghoum M, Biron P.
    Support Care Cancer; 2008 Sep 01; 16(9):1017-23. PubMed ID: 18197434
    [Abstract] [Full Text] [Related]

  • 10. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
    Carstensen M, Sørensen JB.
    J Support Oncol; 2008 Sep 01; 6(5):199-208. PubMed ID: 18551855
    [Abstract] [Full Text] [Related]

  • 11. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M, Meran JG, Geissler RG, Böhme A, Jürgens H, Ganser A.
    Wien Med Wochenschr; 1998 Sep 01; 148(18):427-32. PubMed ID: 9888179
    [Abstract] [Full Text] [Related]

  • 12. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G, Sunderland T, Chan KW, Rolston K, Mullen CA.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):273-7. PubMed ID: 16435377
    [Abstract] [Full Text] [Related]

  • 13. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.
    J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529
    [Abstract] [Full Text] [Related]

  • 14. A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies.
    Cherif H, Björkholm M, Engervall P, Johansson P, Ljungman P, Hast R, Kalin M.
    Scand J Infect Dis; 2004 Sep 01; 36(8):593-600. PubMed ID: 15370671
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD.
    J Clin Oncol; 2013 Feb 20; 31(6):794-810. PubMed ID: 23319691
    [Abstract] [Full Text] [Related]

  • 16. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM, Herrera L, Sandler ES, Buchanan GR.
    Cancer; 2000 Apr 01; 88(7):1710-4. PubMed ID: 10738231
    [Abstract] [Full Text] [Related]

  • 17. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
    Kebudi R, Görgün O, Ayan I, Gürler N, Akici F, Töreci K.
    Med Pediatr Oncol; 2001 Apr 01; 36(4):434-41. PubMed ID: 11260566
    [Abstract] [Full Text] [Related]

  • 18. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
    McMeekin DS, Gazzaniga C, Berman M, DiSaia P, Manetta A.
    Gynecol Oncol; 1996 Aug 01; 62(2):247-53. PubMed ID: 8751557
    [Abstract] [Full Text] [Related]

  • 19. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
    Bellesso M, Costa SF, Pracchia LF, Santos Dias LC, Chamone D, Dorlhiac-Llacer PE.
    Ann Hematol; 2011 Apr 01; 90(4):455-62. PubMed ID: 20852999
    [Abstract] [Full Text] [Related]

  • 20. Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients.
    Oude Nijhuis C, Kamps WA, Daenen SM, Gietema JA, van der Graaf WT, Groen HJ, Vellenga E, Ten Vergert EM, Vermeulen KM, de Vries-Hospers HG, de Bont ES.
    J Clin Oncol; 2005 Oct 20; 23(30):7437-44. PubMed ID: 16234511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.